NASDAQ: ARTL
Artelo Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for ARTL

Based on 1 analyst offering 12 month price targets for Artelo Biosciences Inc

Min Forecast
$18.00+266.6%
Avg Forecast
$18.00+266.6%
Max Forecast
$18.00+266.6%

Should I buy or sell ARTL stock?

Based on 1 analyst offering ratings for Artelo Biosciences Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ARTL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ARTL as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their ARTL stock forecasts and price targets.

ARTL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-26

1 of 1

Forecast return on equity

Is ARTL forecast to generate an efficient return?

Forecast return on assets

Is ARTL forecast to generate an efficient return on assets?

Company
N/A
Industry
23.46%

ARTL earnings per share forecast

What is ARTL's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$11.04

ARTL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARTL$4.91$18.00+266.60%Strong Buy
ACXP$4.12$143.67+3,387.06%Buy
NLSP$2.03N/AN/A
SILO$0.70N/AN/A
PMCB$0.93N/AN/A

Artelo Biosciences Stock Forecast FAQ

Is Artelo Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ARTL) stock is to Strong Buy ARTL stock.

Out of 1 analyst, 1 (100%) are recommending ARTL as a Strong Buy, 0 (0%) are recommending ARTL as a Buy, 0 (0%) are recommending ARTL as a Hold, 0 (0%) are recommending ARTL as a Sell, and 0 (0%) are recommending ARTL as a Strong Sell.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.

What is ARTL's earnings growth forecast for 2025-2025?

(NASDAQ: ARTL) Artelo Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.28%.

Artelo Biosciences's earnings in 2025 is -$10,503,000.

In 2025, ARTL is forecast to generate -$14,587,027 in earnings, with the lowest earnings forecast at -$14,587,027 and the highest earnings forecast at -$14,587,027.

What is ARTL's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ARTL) forecast ROE is N/A, which is considered weak.

What is ARTL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ARTL price target, the average ARTL price target is $18.00, with the highest ARTL stock price forecast at $18.00 and the lowest ARTL stock price forecast at $18.00.

The Wall Street analyst predicted that Artelo Biosciences's share price could reach $18.00 by Aug 26, 2026. The average Artelo Biosciences stock price prediction forecasts a potential upside of 266.6% from the current ARTL share price of $4.91.

What is ARTL's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ARTL) Artelo Biosciences's current Earnings Per Share (EPS) is -$19.05. In 2025, ARTL's EPS is forecast to hit -$11.04 (min: -$11.04, max: -$11.04).

What is ARTL's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ARTL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 23.46%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.